|
Annals of African Medicine
Annals of African Medicine Society
ISSN: 1596-3519
Vol. 6, Num. 2, 2007, pp. 45-50
|
Annals of African Medicine, Vol. 6, No. 2, 2007, pp. 45-50
Management of Hyperglycaemic Emergencies in the
Tropics
F. O. Anumah
Department of Medicine, Ahmadu Bello University Teaching Hospital, Zaria, Nigeria
Reprint requests to: Dr. F. O. Anumah, Department of
Medicine, Ahmadu Bello University Teaching Hospital, Shika, Zaria, Nigeria
Code Number: am07012
Abstract
Diabetic ketoacidosis (DKA) and hyperglycaemic
hyperosmolar state are the two most serious acute metabolic complications of
diabetes even if managed properly. These disorders can occur in both types 1and
2 diabetes, and remain an important cause of morbidity and mortality in
diabetic populations especially, in the developing countries. Intravenous
insulin and fluid replacement are the mainstays of therapy, with careful
monitoring of potassium levels. Bicarbonate therapy is rarely needed.
Infection, omission of insulin, and other precipitating factors should be
treated. This review is intended to discuss some of the advances in the
management of hyperglycaemic emergencies and also to highlight some of the peculiarities
of the management of hyperglycaemic emergency in our setting if we are going to
be able to improve outcome significantly.
Key words: Hyperglycaemic emergencies,
diabetic ketoacidosis, hyperglycaemic hyperosmolar, fluid therapy, insulin
therapy
Résumé
Ketoacidose diabétique (DKA) et létat
dhyperglycémique hyperosmolaire sont les deux complications métaboliques
aigues les plus sérieuses des diabètes même si on les avait correctement
soignées. Ces troubles peuvent arriver dans le type 1 et type 2 les deux
diabètes et demeure une cause importante de la morbidité et mortalité dans les
populations diabétiques en particulier, dans les pays en voie de
développement. Insuline intraveneuse et la remise en place du liquide sont les
bases de la thérapie, avec une surveillance soigneuse du niveau du potassium.
La thérapie bicarbonate est rarement exigée. Linfection lomission de
linsuline, et des autres facteurs precipitants devraient être traités. Lobjet
de cette étude est détudier quelques uns de ces progrès dans la prise en
charge des urgences hyperglycémique et aussi de souligner quelques singularités
de la prise en charge dhyperglycémique durgence dans notre milieu si nous
aurions à mésure daméliorer le résultat dune manière remarquable.
Mots-cles: Urgences hyperglycémique, ketoacidose diabétique,
létat dhyperglycémique hyperosmolaire, thérapie de liquide, thérapie de
linsuline
Introduction
Hyperglycaemic
emergencies are the most common endocrinopathy requiring intensive care. Diabetic
ketoacidosis (DKA) and hyperglycaemic hyperosmolar state (HHS) are two extremes
in the spectrum of diabetic decompensation. They remain the most serious acute
metabolic complications of diabetes mellitus and are still associated with
excess mortality. The degree of metabolic derangement in this condition is
severe enough to warrant emergency hospitalization, immediate correction with
intravenous fluids and insulin therapy to improve the patients chance of
survival. 1-3
DKA comprises of metabolic acidosis (pH <7.3),
plasma bicarbonate <15mmol/l, plasma glucose >14mmol/l, and urine
ketostix reaction ++ or plasma ketostix >+. 4, 5 HHS replaces the
older term, hyperglycaemic hyperosmolar non-ketotic state. There is severe
hyperglycaemia >30mmol/l, hyperosomlality >340mOsm/kg, with minimal
ketones in serum or urine. 6, 7 Studies have shown that mixed forms
of DKA and HHS exist rather than either condition alone, suggesting the two
are different parts of the same spectrum. 8, 9
The annual incidence of DKA among subjects with
type 1 diabetes is 1-5% in the western countries and mortality rates are less
than 5% in experienced centers. 6,10,11 However the mortality rate
of patients with HHS still remains high at about 15%. 3, 7, 12. The
prognosis of both conditions is substantially worsened at the extremes of age.
In the developing countries, mortality from hyperglycaemic emergencies is
certainly higher 20-50% due to paucity of facilities, shortage of insulin
supplies and qualified healthcare givers with specialist interest in diabetes
and its complications. 13-15
Pathogenesis
The
basic underlying mechanism for DKA and HHS is a reduction in the net effective
action of circulating insulin coupled with a concomitant elevation of counter
regulatory hormones, such as glucagon, catecholamines, cortisol, and growth
hormone. These hormonal alterations lead to hepatic and renal production and impaired
glucose utilization in peripheral tissues, which result in hyperglycaemia and
parallel changes in osmolality of the extracellular space. 16 The
combination of insulin deficiency and increased counter regulatory hormones
also lead to release of free fatty acids into the circulation from adipose
tissue (lipolysis) and to unrestrained hepatic fatty acid oxidation to ketone
bodies (β-hydroxybutyrate and acetoacetate), with resultant ketonaemia and
metabolic acidosis. In HHS however, the plasma insulin concentration may be
inadequate to facilitate glucose utilization but adequate to prevent lipolysis
and subsequent ketogenesis. 17 Both DKA and HHS are associated with
glycosuria, leading to osmotic diuresis with loss of water, sodium, potassium,
and other electrolytes. 18
Precipitating factors
A
number of deaths due to hyperglycaemic emergencies (HE) arise from failure to
recognize and treat the underlying precipitating factors, rather than the
metabolic disturbances especially in the elderly. Infection remains the most
important precipitating factor in the development of DKA and HHS. In 20-25% of
cases, infections are the first manifestations of previously undiagnosed
diabetes mellitus. 19 Infection, known or undiagnosed especially of
the urinary tract, respiratory tract and skin is the most common precipitating
factor causing more than 50% of identified causes. 4-7 Zouvanis et
al in 1997 reported in Johannesburg Africans that infection was the leading
precipitating factor for both DKA and HHS 20 while Umpierrez et al
in the same year, in Atlanta also reported infections in 34% of patients
presenting with diabetic emergencies. 21
Omissions or inadequate doses of insulin are frequent
precipitating factors, particularly for DKA. 18 Watchel et al found
that omission of insulin was the most common cause identified with the onset of
DKA in those with type 1 diabetes. 8 Other precipitating factors,
especially for HHS, are silent myocardial infarction, cerebrovascular accident,
mesenteric ischaemia, acute pancreatitis and use of medications such as
steroids, thiazide diuretics, calcium-channel blockers, propranolol and
phenytoin. 22 In 2-10% of cases of DKA, no obvious precipitating
factor can be identified. 21
The clinical implication of precipitating factors is
that all of them trigger release of one or more of the catabolic hormones such
as glucagon, cortisol, catecholamines and growth hormones. These worsen the
relative insulin deficiency that exists. Often patients mistakenly take less
insulin because of decreased food intakes, thus magnifying the effects of the
catabolic hormones. 2, 3, 18-22
Diagnosis
of Hyperglycaemic Emergencies
The
initial diagnosis of hyperglycaemic emergency can usually be made rapidly at
the bedside by a combination of history, physical examination and simple
diagnostic tests. However, a high index of suspicion is necessary in elderly
patients and in non-ketotic cases that may present with nonspecific symptoms
and signs.
DKA usually occurs in younger, lean patients with type
I diabetes and develops within a day or so. When DKA occurs in individuals with
type 2 diabetes, the precipitating illnesses are usually severe. Common
symptoms that may be premonitory include dry mouth, polyuria, polydipsia,
polyphagia, weight loss and weakness. These may blend rapidly into the symptoms
related to ketoacidosis namely nausea and vomiting, laboured and increasingly
deep rapid respiration (Kussmaul Kien respiration), prostration, drowsiness,
abdominal pain, muscle cramps and altered state of consciousness. 2, 21-23 HHS occurs more commonly in older, obese patients with type 2 diabetes and can
take days to weeks to fully develop.
Physical examination will usually reveal profound
dehydration, which could be very severe in HHS, evidenced by tachycardia,
hypotension (especially postural hypotension), dry skin and dry mucous
membranes. In DKA, compensatory hyperventilation (Kussmaul breathing) is
present. The breath may have the odour of nail vanish remover, the result of
acetone produced by the decarboxylation of acetoacetate in the liver. Other
findings are hypothermia and varying degrees of altered state of consciousness.
Coma is reported to be present in <20%, and is associated with mortality
rate of 15% to 20%. 4-11, 17 Mental obtundation and coma are more
frequent in HHS because of hyperosmolarity, and focal neurological signs and
seizures have been described. 16, 24
Bedside biochemistry will confirm plasma glucose
between 300 1000 mg/d1 and urine ketones ++ or more in DKA, patients with HHS
have blood glucose concentration between 450 - 2000mg/d1. 4, 16,17 A
more detailed biochemical investigation may show hypernatremia, elevated blood
urea with calculated plasma osmolality, usually greater than 330mosm/1 in HHS
patients. 7, 16 Glucose is the main osmole responsible for the
hyperosmolar syndrome. The increased serum osmolality can be calculated as follows:
(2 serum Na) + serum glucose mosmol/l. 17, 24 In lactic acidosis,
blood glucose concentration is usually normal or just slightly elevated, with
markedly reduced bicarbonate level. 16
Recent studies have found that it is not uncommon to find
mixed cases of diabetic acidosis and hyperosmolality. These are patients with a
bicarbonate level <15mmo1/1, pH of 7.3 or less, and increased serum
osmolality. 8, 25 The second group of patients identified are those
with hyperglycaemia, normo-osmolality with no significant acidosis. 7
Management
of Hyperglycaaemic Emergencies
Principles of treatment
The
best form of treatment prevention. Adequate education of patient, the general
practitioner and hospital physical could prevent cases or at least ensure that
they were referred while still mild. 2, 4-7 Once the diagnosis is
established, the aim is the smooth restoration to normal, of the disordered
clinical and biochemical states. In addition, treatment of the precipitating
factor is very necessary to reduce morbidity and mortality. The therapeutic
goals are to improve circulatory volume and tissue perfusion, decrease serum
glucose level, clear the serum and urine of ketoacids at a steady rate and
correct the electrolyte imbalance.
Fluid therapy
Disturbances
in hydration and electrolyte balance are of great importance in hyperglycaemic
emergencies and required prompt and aggressive therapy. The first priority
therefore is fluid replacement. Fluid replacement alone will lower blood
glucose. Tracer studies have found that during the first four hours of therapy
for DKA, up to 80% of the decline in glucose concentration may be caused by
rehydration. 23, 26 There is increase in renal blood flow with
resultant glycosuria and osmotic diuresis, along with decrease in the levels of
the counter regulatory hormones and blood ketones bodies concentration. These
make the response to physiologic does of insulin more predictable. 2, 4,
26, 27
An average adult patient in DKA will have a deficient
of 5-7 litres of water, 500-700 mmol of sodium, 200-350mmol of potassium,
350-500mmol of phosphate, and 200-350mmol of chloride. 6,28Intravenous
fluid should aim to correct these water and electrolyte deficits over the first
24-48hpurs. In most adults with moderate or severe DKA there is a deficit of
approximately 5 litres, plasma osmolality > 330mosm/kg are associated with
large fluid deficits and plasma osmolality can be correlated with mental
status.
Isotonic saline is generally accepted as the most
appropriate initial replacement fluid. 23, 26, 27 This is because
the rise in plasma sodium is gradual, thus balancing the fall in blood glucose
osmoles and therefore plasma osmolality falls only gradually. Infusion of 1-1.5
litres (5-20ml/kg/hour) of 0.9% saline in the first hour is appropriate in most
cases, subsequently 250-1000ml/hour for the next four hours (4-14ml/kg/hour).
If corrected sodium concentrations are high (> 155mml/l) after the initial
1-2 litres of normal saline, 0.45% saline should be considered. However it is
recommended that no more than one litre should be given over eight hours. 6,16,29 Once plasma glucose falls to <14mmol/l then 5% dextrose (10% dextrose if
less fluid/more insulin required) should be started at 100-125ml/hour and 0.9%
saline continued at a slower rate to complete rehydration and electrolyte
replacement.
In HHS, there is an average deficit of 10.5 litres of
water, 350-900mmol of sodium, 350-1050mmol of potassium, 210-490mmol of
chloride, 70-150mmol of phosphate and 70-140mmol of magnesium. 17, 28 Presently, fluid replacement in HHS is guided by the plasma sodium
concentration. Initially 0.9% saline is given at the rate of 5-20ml kg/hour in
the first hour, subsequently 500-1000ml/hour for 4 6 hours depending on the
degree of dehydration then it is slowed as necessary. 3, 27 However,
it is recommended that effective serum osmolality should not change by >
3mosm/kg/hour. 4
Insulin therapy
Hyperglycaemic
emergency is a life threatening complication of diabetes resulting from severe
insulin deficiency. The aim of insulin administration is to restore normal
homeostasis. Insulin inhibits lipolysis, ketogenesis, and gluconeogenesis. In
addition, improves extrahepatic utilization of glucose and ketone bodies, and
restores normal transmembrane electrolyte balance. 2, 4,17,18,21
In the past, many different regimens of insulin
administration were advocated in the management of HE. Phear in 1963 was
reported to have stated that the more severe the acidosis, the more insulin is
needed, while some other authors were guided by the blood glucose levels. 30 Until mid 1970s, insulin was generally given intravenously, intramuscularly
and/or subcutaneously as bolus injections. 31 But the technique of
intravenous infusion of insulin is said to have been first described by Rossier
et al in 1960, with an initial dos of 100 units per hour. Infusion of low dose
insulin in the management of HE was reported to have been described later by
Sonksen et al in 1972 who used amounts between 1.5 to 12 units per hour. 30
Low dose insulin regimen is now widely accepted in
preference of large dose of insulin. 32, 33 Alberti et al 34 found no advantages for large doses of insulin, which carry the risks of
hypoglycaemia, hypokalaemia and hyperlactaemia. He used small hourly doses of
insulin, which were given intramuscularly to achieve adequate blood
concentrations and found this regimen effective in the management of patients
with HE.
Presently, the continuous insulin infusion and the
bolus intramuscular or intravenous injections of low dose insulin are used in
the management of HE. 16,29,32-34 The constant intravenous infusion
of insulin is the gold standard and has advantages over the intermittent
regimen; these include immediate onset of
action, maintenance of a steady blood concentration in the effective range and
avoidance of the vagaries of absorption from tissue depots. In addition, it
overcomes the problem of the short half life of intravenous insulin given in
boluses and can be altered or ended almost instantaneously. 30, 32, 34 It is usually started as a continuous infusion of six units per hour of fast
acting insulin. The aim is to bring plasma glucose concentration down by
3-5mmol/l/hour. If plasma glucose does not fall by 3mmol/l in the first hour,
and hydration status appropriately treated, then the dose of insulin may be
doubled. When plasma glucose levels are <14mmol/l the rate of infusion may
be decreased to 3units/hour and intravenous dextrose started. Insulin and
glucose infusions should be adjusted to maintain plasma glucose between
8-12mmol/l until the acidosis has resolved when regular insulin therapy may
start if the patient is able to eat and drink. 18, 22, 28, 29
The full effect to intramuscular injection of insulin
is not apparent until the insulin is completely absorbed. The time required for
absorption following intramuscular injection is variable, particularly when the
volume status of the patient is rapidly changing, and thus the risk for
hypoglycaemia is not easily predictable in any given patient. 30, 32, 34
Although the intermittent intramuscular route of
insulin administration has the disadvantages mentioned above, it is better
suited for developing countries like ours, where medical and biochemical
services are grossly inadequate. The American Diabetes Association position
statement suggests that 0.4 units of fast acting insulin/kg body weight are
given, half as an intravenous bolus, half subcutaneously or intramuscularly as
a statim dose, and then 0.1 units/kg are given intramuscularly each hour until
plasma glucose is less than 14mmol/l. At this stage 5-10 units of fast acting
insulin are administered every two hours, with concomitant dextrose infusion,
until normal insulin can be started. 29 The advantages are in the
fact that it does not require any special instruments and it is simple to
follow. Also complex apparatus and complicated calculations of insulin doses
are not necessary, timing of insulin injections are straight forward, the rate
of fall in plasma glucose is predictable and blind injections may be given for
2-3 hours before blood sugars are obtained.
Potassium therapy
The
treatment of DKA and HHS with rehydration and insulin is typically associated
with a rapid decline in the plasma potassium concentration, particularly during
the first few hours of therapy. 21, 28 This rapid decrease is due to
several factors, the most important being the insulin mediated re-entry of
potassium into the intracellular compartment. Other factors are correction of
acidosis, increased urinary loss, extracellular fluid volume expansion, and
secondary hyperaldosteronism. It is recommended that potassium replacement
should commence as soon as hyperkalaemia is excluded. If potassium levels are
between 3.3-3.5mmol/l then give 20-30mmol of potassium added to each litre of
infused fluid in early stages of treatment. Aim is to keep potassium >
4mmol/l. if the serum potassium level is less than 3.3 mmol/L, then the
patient is at risk of cardiac arrhythmia and muscle weakness with institution
of insulin therapy. This should be withheld until plasma potassium has been
corrected by infusion of potassium at 40mmol/hour. 6, 16, 17 Our
practice is to start potassium replacement between the second and third hour
after commencement of fluid therapy when usually satisfactory urine output
would have been achieved in the patients.
Bicarbonate therapy
The
use of bicarbonate in the treatment of DKA remains controversial. 21, 35 Bicarbonate replacements are recommended, only if the pH level is below 6.9 or
serum bicarbonate level is lower than 10.mmol/L. 4, 9,18,21,35 This
is because bicarbonate administration is associated with risks such as
hypokalaemia, induction of paradoxical central nervous system acidosis,
worsening of intracellular acidosis owing to increased carbon dioxide
production and prolongation of ketoanion metabolism. If indicated, 100mmol of
sodium bicarbonate infused with 20mmol potassium chloride over 30minutes is the
recommended dose, with serial monitoring of calcium and potassium. In our
practice, bicarbonate level usually normalizes with rehydration thus avoiding
the need for replacement. Could it be that our patients are not presenting with
very severe acidosis?
Phosphate
Although
the phosphate level frequently is low in patients with DKA, studies have shown
that routine phosphate replacement does not improve outcome in DKA, thus if the
patients serum phosphate level is below normal, one third of the potassium may
be given in the form of potassium phosphate, provided the level of serum
calcium is monitored closely. 22, 23
Sodium
The
whole body sodium deficits typically are 7-10mmol/l. serum sodium is falsely
lowered by 1.6mmol for every 100mg/l increase in blood glucose. Hyponatraemia
needs to be corrected only when the sodium is still low after adjusting for
this effect. 23
Complications
of Treatment of Hyperglycaemic Emergencies
The
most common complications of DKA and HHS include hypoglycaemia due to
overzealous treatment with insulin, hypokaelemia due to insulin administration
and treatment of acidosis with bicarbonate, and hyperglycaemia due to
interruption/discontinuation of intravenous insulin therapy after recovery
without subsequent coverage with subcutaneous insulin.
Commonly, patients recovering from DKA develop hyperchloraemia
caused by the use of excessive saline for fluid and electrolyte replacement
and metabolic acidosis as chloride from the fluids replaces ketoanions lost as
sodium and potassium salts during osmotic diuresis. These biochemical
abnormalities are transient except in cases of acute renal failure. 4,
6,9,29
Cerebral oedema
This
is rare but frequently fatal complication of DKA, occurring in 0.7-1% of
children with DKA, can also occur in young people in their twenties. 36 Fatal cases have been reported with HHS. Clinically cerebral oedema is
characterized by deterioration in the level of consciousness, with lethargy,
decrease in arousal and headache. Neurological deterioration may be rapid, with
seizures, incontinence, papillary changes, bradycardia and respiratory arrest.
Once the clinical symptoms other than lethargy and behavioral changes occur,
mortality is high (>70%) with only 7-14% of patients recovering without
permanent morbidity.
Although the mechanism of cerebral oedema is not
known, it likely results from osmotically driven movement of water into the
central nervous system when plasma osmolality declines too rapidly with the
treatment of DKA and HHS. Prevention in high risk patients are gradual
replacement of sodium and water deficits in patients who are hyperosmolar
(maximal reduction in osmolality 3mOsm/kg, and the addition of dextrose to the
hydration solution once blood glucose reaches <14mmol. 4, 36
Adult respiratory distress syndrome
Hypoxaemia
and rarely noncardiogenic pulmonary oedema may occur at presentation of DKA or
few hours after the onset of treatment. Hypoxaemia is attributable to a
reduction in colloid osmotic pressure that results in increased lung water
content and decreased lung compliance. Patients who have a widened alveolo-
arteriolar oxygen gradient on initial blood gas measurement or with pulmonary
rales on physical examination appear to be at higher risk. 2, 37, 38
Vascular thrombosis
Many
features of DKA and HHS predispose the patient to thrombosis: dehydration and
contracted vascular volume, low cardiac output, increased blood viscosity and
the frequent presence of underlying atherosclerosis. In addition a number of
haemostatic changes favour thrombosis and this complication more likely when
osmolality is very high. Low molecular- weight heparin should be considered for
prophylaxis in patients at high risk of thrombosis. 39
Conclusion
Many
cases of hyperglycaemic emergencies are preventable. A major part of the challenge
is to ensure proper management of the African diabetic to prevent
complications. This will include: Improved education and effective
communication with those with diabetes in order to prevent admissions with DKA
and HHS. Educating the healthcare givers including nurses, general
practitioners and physicians with adequate diagnostic and therapeutic knowledge
of the management of diabetes and hyperglycaemic emergencies.
The observation that stopping insulin for economic
reasons is a common precipitant in the tropics is disturbing and underscores
the need for the health care delivery systems to address this problem. These
measures should reduce morbidity and the unacceptably high mortality
significantly in the developing countries.
References
-
Butkiewiez EK, Leibson CL,
Obrien PC. Insulin therapy for diabetic
ketoacidosis. Diabetes Care 1995; 18: 118 - 119
-
Kitabchi AE, Wall BM. Diabetic
ketoacidosis. Med Clin North Am 1995; 79: 9 - 37
-
Wachtel TJ. The diabetic
hyperosmolar state. Clin Geriatr Med 1990; 6: 7797 - 7806
-
American Diabetes Association.
Hyperglycaemic crisis in patients with diabetes mellitus (position statement).
Diabetes Care 2001; 24: 154 - 161
-
Westphal SA. The occurrence of diabetic
ketoacidosis in non-insulin dependent diabetes and newly diagnosed diabetic adults.
Am J Med 1996; 10: 19 - 24
-
Kitabchi AE, Umpierrez GE, Murphy
MB, et al. Management of hyperglycaemic crisis in patients with diabetes.
Diabetes Care 2001; 24: 131 - 153
- Rolfe M, Ephraim GG, Lincoln DC,
Huddle KRL. Hyperosmolar nonketotic diabetic coma as a cause of emergency
hyperglycaemic admission to Baragwanath Hospital. S Afr Med J 1995; 83: 174 -
176
- Wachtel TJ, Tetu-Mauradjian LM,
Goldman Dl, Elis SE, O Sullivan PS. Hyperosmolarity and acidosis in diabetes
mellitus. J Gen Intern Med 1991; 6: 495 - 500
- American Diabetes Association.
Hyperglycaemic crisis in patients with diabetes mellitus. Diabetes Care 2002; 25:
154 - 170
- Krentz AJ, Nattrass M. Acute
metabolic complications of diabetes: diabetic ketoacidosis, hyperosmolar
non-ketotic hyperglycaemia, and lactic acidosis. In: Pickup JC, Williams G (eds).
Textbook of diabetes. Blackwell, Oxford, 2003; 32.1-32.24
- Umpierrez EG, Kelly SP, Navarrete
JE, Casals MMC, Kitabchi AE. Hyperglycaemic crisis in urban Blacks. Arch Intern
Med 1997; 157: 669 - 675
- Fishbein HA, Palumbo PJ. Acute
metabolic complications in diabetes. In: Group NDD (ed). Diabetes in America.
National Institute of Health, Bethesda, 1995; 283-291
- Gill G. Practical management of
diabetes in the tropics. Trop Doct 1990; 20: 4 - 10
- Akanji AO. Diabetic hyperglycaemic
coma: pathophysiology, clinical features and problem of management in
developing counties.Nigerian Medical Practitioner 1990; 19: 43 - 49
- Savage A. The insulin dilemma: a survey
of insulin treatment in the tropics. International Diabetes Digest 1994; 105:
19 - 20
- English P, Williams G. Hyperglycaemic
crisis and lactic acidosis in diabetes mellitus. Postgrad Med J 2004; 80: 253 -
261
- Ennis ED, Stall E,
Krisberg RA. The hyperosomolar
hyperglycemic syndrome. Diabetic Rev 1994; 2:115 - 26
- Ennis ED, Kreisberg RA. Diabetic
ketoacidosis and the hyperglycaemic hyperosmolar syndrome. In: Le Roith D,
Taylor SI, Olefsky JM (eds). Diabetes mellitus. A fundamental and clinical
text. Lippincott, William and Wilkins, Philadelphia, 2000; 336 - 347
- American Diabetes Association.
Hyperglycaemic crisis in patients with diabetes mellitus. Diabetes Care 2003; 2
(suppl 1) S109 - S117
- Zouvanis M, Pieterse AC, Seftel
HC, Joffe BI. Clinical characteristics and outcome of hyperglycaemic emergencies
in Johannesburg Africans. Diabetic Medicine 1997; 14: 603 - 606
- Umpierrez GE, Khajari M, Kitabchi
AE. Review: diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic
syndrome. Am J Med Sci 1996; 311: 225 - 233
- Kitabchi AE, Umpierrez GE, Murpy
MB, et al. Hyperglycemic crisis in diabetes. Diabetes Care 2004; 27 (suppl 1):
S94 - S102
- Stoner GD. Hyperosmolar
hyperglycaemic state .Am Fam Physician 2005; 71: 1723-173.
- Marshall SM, Albertic KGMM.
Hyperglycemic emergencies and surgery: an update. Diabetes Ann 1990; 15: 397
- 433
- Lober D. Nonketotic hypertonicity
in diabetes mellitus. Med Clin North Am 1995; 79:39-52
- Schade DS, Eaton RP. Diabetic ketoacidosis
- pathogenesis, prevention and therapy. Clin Endocrinol Metab 1983; 12:; 321 - 338
- Caputo DG, Villarejo F, Valle GB,
et al. Hydration in diabetic ketoacidosis. What is the effect of the infusion
rate? Medicina 1997; 57: 15-20
- Marshall SM, Walker M, Alberti
KGM. Diabetic ketoacidosis and hyperglycaemic non-ketotic coma. In: Alberti
KGM, Zimmet P, DeFronzo RA (eds). International textbook of diabetes mellitus. Wiley,
New York, 1997; 1215-1229
- Chiasson JL, Aris-Jilwan N,
Belanger R, et al. Diagnosis and treatment of diabetic ketoacidosis and the hyperglycaemic
hyperosmolar state. Can Med Assoc J 2003; 168: 859 - 866
- Page MM. Treatment of diabetic
coma with continuous low dose infusion of insulin. Br Med J 1974; 2: 687 - 690
- Hayton WL, Grisafe JA, Pullman BP.
Pharmacokinetic evaluation of dosing regimen for insulin in diabetic ketoacidosis.
Diabetes 1976; 25: 771-775
- Padilla AJ, Loeb JN. Low-dose versus
high-dose insulin regimens in the management of uncontrolled diabetes. Am J
Med 1977; 63: 843 - 848
- Kidson W, Casey J, Kraegen E,
Lazarus L. Treatment of severe diabetes mellitus by insulin infusion. Br Med J
1974; 2: 691 - 694
- Alberti KGMM, Hockaday TDA, Turner
PC. Small doses of intramuscular insulin in the treatment of diabetic coma.
Lancet 1973; 8: 515 - 522
- Morris LR, Murphy MB, Kitabchi AE.
Bicarbonate therapy in severe diabetic ketacidosis. Ann Intern Med 1986; 105:
836 - 840
- Marcin JP, Gennis V, Barnett P, et
al. Factors associated with adverse outcomes in children with DKA-related
cerebral oedema. J Pediatr 2002; 141: 793 - 797
- Holsclaw DS Jr, Torcato B. Acute
pulmonary edema in juvenile diabetic ketoacidosis. Pediatr Pulmonol 1997; 24:
438 - 443
- Carel P, Matz R. Adult respiratory
distress syndrome complicating severely uncontrolled diabetes mellitus: report
of nine cases and a review of literature. Diabetes Care 1982; 55: 574 580
- Paton RC. Haemostatic changes in
diabetic coma. Diabetologia 1981; 21: 172-177
Copyright 2007 - Annals of African Medicine
|